Regorafenib and XmAb20717 in Treatment of High-risk Patients With Colorectal Cancer With Radiographic Occult Molecular Residual Disease After End of Established Definitive Therapy (RX-CROME)
Clinical trial NCT05900648 · WITHDRAWN
Trial details
- NCT number
- NCT05900648
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-17
- Primary completion
- 2024-02-09
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.